Stocks in play: Pond Technologies Holdings Inc.

Announced that on August 23, 2018, it entered into a non-binding letter of intent to acquire all of the issued and outstanding shares of Regenurex Health Corporation, a British Columbia based owner and operator of an algae production facility, engaged in the cultivation and extraction of astaxanthin, a valuable nutraceutical product. Driven by the demonstrated synergies of the two companies, Pond will acquire the Regenurex brand, plant, and related production assets, through acquisition of the Purchased Shares for a minimum of $2,269,599, comprised of $500,000 cash to be invested in Regenurex in consideration for the issuance to Pond of Regenurex common shares and 737,333 Pond shares valued at $2.40 per share. The LOI provides for an additional earn-out of up to 3,154,658 Pond shares at a deemed value of $2.40 for a maximum capped value of $7,595,180, pro-rated, based upon actual achieved financial performance of Regenurex in 2020. Pond Technologies Holdings Inc. shares V.POND are trading up 5 cents at $1.35.